GT Molecular SARS-CoV-2 Variant Assay Panel for Qiagen QIAcuity

GT Molecular has launched a SARS-CoV-2 variant assay panel for the Qiagen QIAcuity digital PCR system.

The SARS-CoV-2 Variant Assay Panel kit targets nine mutations in the spike protein-encoding gene which can be used to indicate the presence of seven variants of concern. The kit has been optimised for use with the QIAcuity platform, includes all necessary controls, and is available immediately in the US and Canada.